is a drug development company that sources late-stage discovery projects from academia and spin-out companies, conducts early proof-of-principle clinical studies and subsequently out-licenses the resulting programs to the pharmaceutical and biotechnology industries.

More about us

News

Privacy policy

 

Recent News

Modern Biosciences announces collaboration with Johnson & Johnson Innovation and Janssen for novel oral therapies for rheumatoid arthritis

Learn more...

Modern Biosciences wins £2.4 million award from UK Government’s Biomedical Catalyst

Learn more...

Hosted by ITS | IT Support and Phone System London